Prednisolone (Millipred)
General information
Class/mechanism: Corticosteroid, glucocorticoid.[1][2][3]
Route: PO, gtt (ophthalmic eye drops)
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL)
- Coagulopathies
- Diffuse large B-cell lymphoma
- Extranodal NK/T-cell lymphoma, nasal type
- Follicular lymphoma
- Hodgkin lymphoma
- Mantle cell lymphoma
- Marginal zone lymphoma
- Multiple myeloma
- Prostate cancer
Patient drug information
- Prednisolone (Millipred) patient drug information (Chemocare)[4]
- Prednisolone (Millipred) patient drug information (UpToDate)[5]
Also known as
AsmalPred Plus, Bubbli-Pred, Cotolone, Delta-Cortef, Flo-Pred, Hydeltra-TBA, Hydeltrasol, Key-Pred, Key-Pred SP, Medicort, Millipred DP, Orapred, Orapred ODT, Pediapred, Pred-Ject-50, Predacort 50, Predaject-50, Predalone 50, Predate-50, Predcor, Predicort RP, Predicort-50, Prelone, or Pri-Cortin 50, Veripred 20.
References
- Drug index
- Steroids
- Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) medications
- Coagulopathy medications
- Diffuse large B-cell lymphoma medications
- Extranodal NK/T-cell lymphoma, nasal type medications
- Follicular lymphoma medications
- Hodgkin lymphoma medications
- Mantle cell lymphoma medications
- Marginal zone lymphoma medications
- Multiple myeloma medications
- Prostate cancer medications
- Drugs FDA approved in 1955